首页> 外文期刊>Circulation journal >Target Intensity of Anticoagulation With Warfarin in Japanese Patients With Valvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry –
【24h】

Target Intensity of Anticoagulation With Warfarin in Japanese Patients With Valvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry –

机译:日本瓣膜性心房颤动患者抗凝华法林的目标强度– J-RHYTHM注册表的亚分析–

获取原文
           

摘要

Background: Warfarin is widely used for prevention of thromboembolism in patients with valvular atrial fibrillation (AF), and an international normalized ratio (INR) of prothrombin time between 2.0 and 3.0 is recommended. Optimal intensity of anticoagulation with warfarin in Japanese patients with valvular AF, however, has not been clarified thoroughly as yet. Methods?and?Results: We evaluated the status of anti-thrombotic therapy and incidence rates of events in 410 patients with mitral stenosis and/or mechanical valve replacement (valvular AF) among 7,816 patients with AF followed in the J-RHYTHM Registry. Patients were divided into 5 groups based on INR (
机译:背景:华法林被广泛用于预防瓣膜性房颤(AF)患者的血栓栓塞,建议将凝血酶原时间的国际标准化比率(INR)在2.0和3.0之间。然而,日本瓣膜性房颤患者使用华法林的最佳抗凝强度尚未完全阐明。方法和结果:我们在J-RHYTHM注册表中评估了7,816例AF患者中的410例二尖瓣狭窄和/或机械瓣膜置换(瓣膜性AF)患者的抗血栓治疗状况和事件发生率。根据INR将患者分为5组(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号